-
Daratumumab subcutaneous preparations for the treatment of multiple myeloma: CHMP takes a positive view
Time of Update: 2020-06-24
Genmab Pharmaceuticals today announced that the European Medicines Agency (EMA) Human Medicines Commission (CHMP) has issued a positive opinion on the use of daratumumab subcutaneous preparations fo
-
Blood: Full exome sequencing clears that the rare variation of STAB2 is closely related to VTE
Time of Update: 2020-06-24
Deep vein thrombosis and pulmonary embolism, collectively known as venous thromboembolism (VTE), are the third leading cause of cardiovascular disease death in the United States The Whole Genome Ass
-
FDA Grants Kymriah Advanced Treatment for Sefolioma Regenerative Medicine (RMAT)
Time of Update: 2020-06-24
Novartis today announced that the U.S Food and Drug Administration (FDA) has awarded Kymriah ® advanced regenerative medicine (RMAT) for treatment of recurrent lysopatomer (r/r) follicle-based lymph
-
Blood: Bleeding and thromboembolism risk and predictive markers in newly crowned virus-infected people
Time of Update: 2020-06-24
Increased D-dipolymer levels in patients with neo-coronavirus ( COVID-19 ) Early reports suggest that patients with new crown virus infection sedituated have a higher incidence of venous thrombo
-
Collection: Collection of Blood Research On April 23, 2020
Time of Update: 2020-06-24
THE BIVV001 is used for haemo philia a https://doi.org/10.1182/blood.2019001292 https://doi.org/10.1182/blood.2019001292 FVIII substitutes to provide comprehensive protection for haemophilia A
-
Blood: Extreme damage to heterogeneous colors accelerates aging of the hematopoietic system
Time of Update: 2020-06-24
Heterogeneous chromatin loss has long been considered a universal mechanism of aging of different species and different types of cells However, the comprehensive analysis of the changes in hematopoi
-
Blood: Plasma particles affect endothelial cells differently when patients with sickle cell disease have different effects on endothelial cells
Time of Update: 2020-06-24
Particles (MPs) are submicron extracellular vesicles that can be detected in large quantities in the blood circulation of patients with sickle cell anemia (SS) Several studies have studied the biolo
-
Blood: The role of the ECM-integrator receptor axis in the abnormal proliferation of primary bone marrow fibrosis macronuclear cells
Time of Update: 2020-06-24
Excessive accumulation of extracellular matrix (ECM) is a marker in primary bone marrow fibrosis (PMF) bone marrow (BM) environments Because cells have the ability to adhere to the surrounding ECM t
-
J Thromb Haemost: Recombinant human soluble thrombosis-regulated protein sepsis efficacy and safety in patients with sepsis-related clotting disorders
Time of Update: 2020-06-24
The efficacy and safety of the recombinant human soluble thrombosis-regulated protein (rhsTM) has not been clearly proven and its effects may depend on the presence or absence of sepsis-related clot
-
Brit J Heamatol: Homocysteine is associated with the severity of microvascular lesions in patients with sickle cell disease
Time of Update: 2020-06-24
The pathophysiological mechanisms of sickle cell disease (SCD) include vascular lesions and anemia Elevated plasma homocysteine is a risk factor for vascular disease and may be associated with an in
-
Lancet Haematol: Ibtinib Joint FCR for initial treatment of young CLL patients: a single arm, multicenter, Phase 2 clinical study
Time of Update: 2020-06-24
FCR programs consisting of fluoradarabin, cyclophosatine and rituximatosis can improve PFS in CLL patients with iGHV mutations in young (-65 years of age) chemotherapy tolerance However, patients wh
-
Blood: Open Conformation of ADAMTS13 - New Biomarkers of Subclinical iTTP
Time of Update: 2020-06-24
Recently, Roose et al found that adamTS13 circulated with open conformation altruism during the acute period of immune-mediated thrombocytopenia reduced cyanosis (iTTP) Although the cause of acute i
-
Blood: Anti-BMP6 antibody combined with EPO to treat chronic anemia!
Time of Update: 2020-06-24
Recombinant erythropoietin (EPO) and iron metabolites are standard treatments for anemia associated with chronic inflammation, including chronic nephrotic anemia A black box that warns of EPO therap
-
J Thromb Haemost: Relationship between platelet reduction and mortality in patients with COVID-19
Time of Update: 2020-06-24
Acute coronavirus 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome (SARS-CoV-2) is spreading rapidly worldwide Platelet reduction in patients with COVID-19 has not been fully analyzed Rec
-
NAT CELL BIO: Li's team develops an efficient cytosine editor
Time of Update: 2020-06-24
Cytosine base editor is a powerful genetic tool for catalyzing the conversion of cytosine to thoracic sine at a specific genomic site, and further improving editing scope and efficiency is essential
-
China NMPA approves first platelet reduction drug for adult patients with chronic liver disease - TPO agonisant DOPTE
Time of Update: 2020-06-24
AkaRx announced that its DOPTELET (Avatrombopag) has been approved by the State Drug Administration (NMPA) to treat platelet reduction in adult chronic liver disease (CLD) patients who plan to under
-
Blood: Long-term prognosis for children with malignant blood disease treated with HSCT
Time of Update: 2020-06-24
There are no prognosis statistics for patients who have reported a child hematopoietic stem cell transplant (HSCT) survivor In this study, Hsiu-Ju Yen and others compared the prevalence of symptoms
-
Blood: Heterogeneous mechanism of hemoglobin-induced expression in sickle cell disease and beta-thalassemia fetal hemoglobin
Time of Update: 2020-06-24
Reversing the switching development of hemoglobin from fetal hemoglobin (HbF, alpha2 x 2) to adult (HbA, alpha2 beta 2) is an important treatment for sickle cell disease (SCD) and beta-thalassemia I
-
NEJM: HLH-case reporting associated with diffuse TB
Time of Update: 2020-06-24
The patient was a 63-year-old man with chronic obstructive pulmonary disease (COPD) who went to the emergency department for fever, shortness of breath and confusion He had a six-month history of fa
-
Brit J Heamatol: Prevalence of non-anemia iron deficiency in the elderly and associated mortality
Time of Update: 2020-06-24
Iron is the core of many biological pathways, and in certain diseases, the treatment of non-anemia iron deficiency (NAID) is beneficial However, it is not clear whether NAID is associated with an in